Thermo Fisher to acquire Olink for $3.1B, expanding proteomics servicesnews2023-10-17T14:58:22+00:00October 17th, 2023|Endpoints News|
Roche partners with Monte Rosa on cancer, neuroscience in $50M upfront discovery dealnews2023-10-17T14:56:06+00:00October 17th, 2023|Endpoints News|
Lumen gets $16M for C. diff drug; Flashpoint’s seed round; Amplifier expands Series Anews2023-10-17T14:43:32+00:00October 17th, 2023|Endpoints News|
Spark taps Barcelona biotech SpliceBio for retinal gene therapy pactnews2023-10-17T07:00:01+00:00October 17th, 2023|Endpoints News|
Bristol Myers scores another Opdivo approval, as Merck converts AA to full approval for Keytruda in MCCnews2023-10-16T20:02:33+00:00October 16th, 2023|Endpoints News|
PhRMA, top Democrats urge Supreme Court to take up abortion pill casenews2023-10-16T19:38:25+00:00October 16th, 2023|Endpoints News|
Lonza partners with Vaxcyte on its pneumococcal vaccine, reveals separate bioconjugate manufacturing dealnews2023-10-16T17:10:10+00:00October 16th, 2023|Endpoints News|
AbbVie’s Skyrizi helps more Crohn’s patients stay off steroids than J&J’s Stelara, PhIII data shownews2023-10-16T15:56:24+00:00October 16th, 2023|Endpoints News|
Atom Bioscience raises $80M in Series D for chronic gout treatmentnews2023-10-16T15:05:13+00:00October 16th, 2023|Endpoints News|
Aldeyra braces for potential dry eye disease rejection after FDA says more data are necessarynews2023-10-16T14:31:21+00:00October 16th, 2023|Endpoints News|
